Register your business to view and bid on tender opportunities published by Public Services and Procurement Canada.
Tender opportunities
Browse the list of tender opportunities and sign up for notifications to stay up to date. To download contracting information posted on CanadaBuys and contract history:
- check out our procurement and contracting datasets
- request your official supplier contract history letter
Content in some tender notices may not be available in both English and French. This is because the Official Languages Act does not apply to all public sector institutions. Learn more about our official languages requirements.
Notice categories:
10 of 11062
Title
|
Category
|
Open/amendment date
|
Closing date
|
Organization
|
|---|---|---|---|---|
| ASSET RETIREMENT OBLIGATIONS CONSULTANT | Services | 2022/10/19 | 2022/10/26 | Marine Atlantic Inc. |
| CONSULTANT EN ÉVALUATION POUR LES ÉVALUATIONS DU CONSEIL D’… | Services | 2019/06/11 | 2019/06/20 | Marine Atlantic Inc. |
| EVALUATION CONSULTANT FOR BOARD EVALUATIONS | Services | 2019/05/30 | 2019/06/05 | Marine Atlantic Inc. |
| IT Security Engineer Services | Services | 2023/02/24 | 2023/03/03 | Marine Atlantic Inc. |
| DATA CENTER RFP DEVELOPMENT CONSULTANT | Services | 2019/09/19 | 2019/09/24 | Marine Atlantic Inc. |
| Business Consultant - Stream 6 PASS | Services | 2019/05/01 | 2019/05/15 | Marine Atlantic Inc. |
| Customs Broker and Freight Forwarder Services RFP Development and… | Services | 2019/12/17 | 2020/01/07 | Marine Atlantic Inc. |
| Fraud Assessment Services | Services | 2023/01/17 | 2023/01/23 | Marine Atlantic Inc. |
| PENSION AUDIT AND CONSULTING SERVICES | Services | 2020/09/17 | 2020/09/29 | Marine Atlantic Inc. |
| BUSINESS CONSULTING SERVICES | Services | 2019/05/30 | 2019/06/13 | Marine Atlantic Inc. |
Displaying 1 - 10 of
10 of 60308
60308
|
Title
|
Category
|
Award/amendment date
|
Closing date
|
Organization
|
|---|---|---|---|---|
| Amend 009 - PERTUSSIS VACCINES - GlaxoSmithKline Inc. | Goods | 2024/09/26 | 2025/03/31 | Department of Public Works and Government… |
| Amend 005 - Hepatitis A and B Adult and Pediatric - GlaxoSmithKline Inc. | Goods | 2025/01/20 | 2025/03/31 | Department of Public Works and Government… |
| Amend 003 - Hepatitis A Adult and Pediatric - GlaxoSmithKline Inc. | Goods | 2025/01/09 | 2025/03/31 | Department of Public Works and Government… |
| Amend 004 - Hepatitis B Adult and Pediatric Vaccine - GlaxoSmithKline… | Goods | 2025/01/09 | 2025/03/31 | Department of Public Works and Government… |
| French Translation Services - Marine Atlantic Inc. | Services | 2021/02/16 | N/A | Marine Atlantic Inc. |
| Financial Advisory Services Consultant in connection with The Allen… | Services | 2020/10/09 | N/A | Parc Downsview Park Inc. |
| Financial Advisory Services Consultant in connection with The Allen… | Services | 2020/10/09 | N/A | Parc Downsview Park Inc. |
| Amend 002 - RISO - UPS System Maintenance - UNIVERSAL POWER SOLUTIONS… | Services | 2023/12/11 | 2025/12/15 | Marine Atlantic Inc. (MarineAtlantic) |
| Marine Satellite Communications - Ship to Shore Vessel Communication | Services | 2021/06/14 | N/A | Marine Atlantic Inc. |
| Dishwasher &Laundry Chemical Supply | Goods | 2020/11/17 | N/A | Marine Atlantic Inc. |
50 of 262094
|
Company name
|
Contract number
|
Organization
|
Award/amendment date
|
Contract / Amendment value
|
|---|---|---|---|---|
| GlaxoSmithKline Inc. | E60PH-21PERT/002/PH | Department of Public Works and Government… | 2024/09/26 | CAD 89,400.00 |
| GlaxoSmithKline Inc. | E60PH-21PERT/002/PH | Department of Public Works and Government… | 2024/09/16 | CAD 89,400.00 |
| GlaxoSmithKline Inc. | E60PH-21PERT/002/PH | Department of Public Works and Government… | 2024/06/28 | CAD 219,924.00 |
| GlaxoSmithKline Inc. | E60PH-21PERT/002/PH | Department of Public Works and Government… | 2024/06/19 | CAD 219,924.00 |
| GlaxoSmithKline Inc. | E60PH-21PERT/002/PH | Department of Public Works and Government… | 2024/02/26 | CAD -195,300.00 |
| GlaxoSmithKline Inc. | E60PH-21PERT/002/PH | Department of Public Works and Government… | 2023/08/11 | CAD -3,641,262.00 |
| GlaxoSmithKline Inc. | E60PH-22HEAB/001/PH | Department of Public Works and Government… | 2025/01/20 | CAD 3,788,170.93 |
| GlaxoSmithKline Inc. | E60PH-22HEPA/002/PH | Department of Public Works and Government… | 2025/01/09 | CAD 1,311,091.54 |
| GlaxoSmithKline Inc. | E60PH-22HEAB/001/PH | Department of Public Works and Government… | 2025/01/09 | CAD 3,788,170.93 |
| GlaxoSmithKline Inc. | E60PH-22HEPA/002/PH | Department of Public Works and Government… | 2024/02/09 | CAD 1,311,091.54 |
| GlaxoSmithKline Inc. | E60PH-22HEAB/001/PH | Department of Public Works and Government… | 2024/02/09 | CAD 3,788,170.93 |
| GlaxoSmithKline Inc. | E60PH-22HEAB/001/PH | Department of Public Works and Government… | 2023/11/29 | CAD 162,250.26 |
| GlaxoSmithKline Inc. | E60PH-22HEAB/001/PH | Department of Public Works and Government… | 2023/08/15 | CAD 277,398.00 |
| GlaxoSmithKline Inc. | 6D034-100134/001/PH | Public Health Agency of Canada | 2022/01/06 | CAD 91,887,813.00 |
| GlaxoSmithKline Inc. | 6D034-100134/001/PH | Public Health Agency of Canada | 2021/05/25 | CAD 522,366,563.00 |
| GlaxoSmithKline Inc. | 6D034-100134/001/PH | Public Health Agency of Canada | 2021/05/10 | CAD 522,366,563.00 |
| GlaxoSmithKline Inc. | 6D034-100134/001/PH | Public Health Agency of Canada | 2021/03/16 | CAD 522,366,563.00 |
| GlaxoSmithKline Inc. | 6D034-100134/001/PH | Public Health Agency of Canada | 2021/02/12 | CAD 522,366,563.00 |
| GlaxoSmithKline Inc. | 6D034-100134/001/PH | Public Health Agency of Canada | 2020/12/07 | CAD 522,366,563.00 |
| GlaxoSmithKline Inc. | 6D034-100134/001/PH | Public Health Agency of Canada | 2020/07/08 | CAD 522,366,563.00 |
| GlaxoSmithKline Inc. | 6D034-100134/001/PH | Public Health Agency of Canada | 2019/05/28 | CAD 522,366,563.00 |
| GlaxoSmithKline Inc. | 6D034-100134/001/PH | Public Health Agency of Canada | 2018/08/14 | CAD 522,366,563.00 |
| GlaxoSmithKline Inc. | 6D034-100134/001/PH | Public Health Agency of Canada | 2018/05/30 | CAD 522,366,563.00 |
| GlaxoSmithKline Inc. | 6D034-100134/001/PH | Public Health Agency of Canada | 2017/08/21 | CAD 522,366,563.00 |
| GlaxoSmithKline Inc. | 6D034-100134/001/PH | Public Health Agency of Canada | 2016/05/13 | CAD 522,366,563.00 |
| GlaxoSmithKline Inc. | 6D034-100134/001/PH | Public Health Agency of Canada | 2015/11/10 | CAD 522,366,563.00 |
| GlaxoSmithKline Inc. | 6D034-100134/001/PH | Public Health Agency of Canada | 2015/03/11 | CAD 522,366,563.00 |
| GlaxoSmithKline Inc. | 6D034-100134/001/PH | Public Health Agency of Canada | 2014/04/22 | CAD 522,366,563.00 |
| GlaxoSmithKline Inc. | 6D034-100134/001/PH | Public Health Agency of Canada | 2014/02/25 | CAD 522,366,563.00 |
| GlaxoSmithKline Inc. | W3931-140077/001/PH | Department of National Defence | 2013/12/13 | CAD 188,640.00 |
| GlaxoSmithKline Inc. | 6D034-100134/001/PH | Public Health Agency of Canada | 2013/11/15 | CAD 522,366,563.00 |
| GlaxoSmithKline Inc. | 6D034-100134/001/PH | Public Health Agency of Canada | 2013/06/13 | CAD 2,627,880.00 |
| GlaxoSmithKline Inc. | 6D034-100134/001/PH | Public Health Agency of Canada | 2012/08/27 | CAD 522,366,563.00 |
| GlaxoSmithKline Inc. | 6D034-100134/001/PH | Public Health Agency of Canada | 2012/06/19 | CAD 522,366,563.00 |
| GlaxoSmithKline Inc. | W3931-080377/001/PH | Department of National Defence | 2011/08/16 | CAD 13,653,300.00 |
| GlaxoSmithKline Inc. | W3931-080377/001/PH | Department of National Defence | 2011/08/05 | CAD 13,653,300.00 |
| GlaxoSmithKline Inc. | 6D034-100134/001/PH | Public Health Agency of Canada | 2011/05/31 | CAD 522,366,563.00 |
| GlaxoSmithKline Inc. | 6D034-100134/001/PH | Public Health Agency of Canada | 2011/05/31 | CAD 1,959,240.00 |
| GlaxoSmithKline Inc. | W3931-110256/001/PH | Department of National Defence | 2011/02/18 | CAD 730,656.00 |
| GlaxoSmithKline Inc. | 6D034-100134/001/PH | Public Health Agency of Canada | 2011/02/15 | CAD 425,891,630.00 |
| GlaxoSmithKline Inc. | EN578-070526/001/PI | Public Works and Government Services… | 2010/10/22 | CAD 33,825,750.00 |
| GlaxoSmithKline Inc. | W3931-110093/001/PH | Department of National Defence | 2010/08/24 | CAD 167,442.00 |
| GlaxoSmithKline Inc. | W3931-100446/001/PH | Department of National Defence | 2010/01/19 | CAD 228,076.00 |
| GlaxoSmithKline Inc. | W3931-100020/001/PH | Department of National Defence | 2009/05/25 | CAD -2,490.00 |
| GlaxoSmithKline Inc. | W3931-080377/001/PH | Department of National Defence | 2009/05/04 | CAD 11,400,000.00 |
| GlaxoSmithKline Inc. | W3931-100020/001/PH | Department of National Defence | 2009/04/16 | CAD 8,490.00 |
| GlaxoSmithKline Inc. | W3931-080377/001/PH | Department of National Defence | 2009/03/16 | CAD 13,653,300.00 |
| GlaxoSmithKline Inc. | W3931-080377/001/PH | Department of National Defence | 2009/03/06 | CAD 426,300.00 |
| GlaxoSmithKline Inc. | W3931-080377/001/PH | Department of National Defence | 2009/01/22 | CAD 1,827,000.00 |
| GlaxoSmithKline Inc. | E60PH-22HEPB/001/PH | Department of Public Works and Government… | 2025/01/09 | CAD 8,257,621.63 |
Useful links
Get an overview of our policies and guidelines, procurement process, and more.
Find out how to prepare for buying or selling to the Government of Canada.
Get all our latest news and learn about upcoming events.
Support
Contact us directly, or find your answers using resource guides.
Call us
Email us
Chat with us
Resources
